Severe muscle injury after methamphetamine use does not establish that methamphetamine was the only cause. A historical 2022 case brought together rapid water intake, a thiazide-containing medicine, seizures, antiretroviral therapy and profound hyponatraemia. Preserving that combination is more informative than reducing the case to a drug-positive label.
What sequence was reported?
A 52-year-old man with HIV and hypertension reported inhaling approximately 0.1 g of methamphetamine. After developing neck discomfort, he drank 6 L of water over about 30 minutes and took three tablets of his usual irbesartan/hydrochlorothiazide medicine. Seizures followed.
Initial serum sodium was 113 mmol/L, creatine kinase 1,979 U/L and creatinine 107 micromol/L. After two days, muscle pain, weakness, dark urine and reduced urine output accompanied a reported creatine kinase of 150,324 U/L. Creatinine subsequently peaked at 632 micromol/L on day four. The patient improved without renal replacement therapy.
Why preserve the serial measurements?
The first creatine-kinase value and the later markedly elevated value describe different times in an evolving illness. An initial result cannot substitute for the later course. Conversely, a later peak should not be presented as though it was measured immediately after the reported inhalation.
Sodium, creatine kinase and creatinine also answer different questions: electrolyte concentration, a marker of muscle injury and a marker used in assessing kidney function. Their parallel trajectories do not make them interchangeable measurements or establish which process started every subsequent change.
Which alternative contributors were present?
The authors considered severe hyponatraemia, methamphetamine exposure, seizure activity and the patient’s antiretroviral regimen. Rapid water intake and thiazide exposure were important parts of the preceding history. These factors were not assigned independently or removed one at a time in an experiment.
The reported methamphetamine amount was a history estimate, not an analytically verified absorbed dose. It provides no blood concentration, product purity or individual susceptibility measurement. Describing it as a small amount cannot by itself exclude a contribution from the drug.
Did the treatment course identify the cause?
No. Management changed as electrolyte disturbance and muscle and kidney injury evolved. Clinical improvement under a sequence of interventions does not quantify each contributor’s causal share. The report is a record of care in one complex presentation, not a comparative test of fluid strategies.
Its title appropriately uses “suspected.” A scientific summary should retain that uncertainty. It should also avoid converting the reported management into a contemporary treatment protocol, because the paper did not compare alternatives or establish a generally applicable regimen.
How should inconsistent units be handled?
The narrative contains some creatinine values labeled in mmol/L, whereas the serial table uses micromol/L. Those units differ by a factor of 1,000. The peak value above follows the table and the accompanying peak description; an apparent unit error should not be reproduced as a plausible physiological measurement.
More broadly, a case report should be checked across its text and tables before using a number in an opinion. Here, the defensible conclusion is that severe hyponatraemia and major muscle injury occurred within a multifactorial exposure and clinical sequence. One patient supplies no incidence estimate, dose threshold or isolated methamphetamine-causation test.
Source
A suspected case of hyponatraemia induced rhabdomyolysis: a case report. BMC Nephrology. 2022;23:180. DOI: 10.1186/s12882-022-02787-7. Full report; bibliographic record.